The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

Clinical trial NCT06494878 · RECRUITING

Trial details

NCT number: NCT06494878
Sponsor: University of Calgary
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism Postpartum Period Aspirin Low Molecular Weight Heparin

Start date: 2026-06-04
Primary completion: 2030-09-01
Enrollment: 8805

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.